Krystal Biotech (KRYS) Free Cash Flow Growth (5y) (2021 - 2026)
Krystal Biotech (KRYS) Free Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Krystal Biotech | 10.38 Bn | 9.56 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.45% |
| Dec 31, 2025 | 56.68% |
| Sep 30, 2025 | 41.55% |
| Jun 30, 2025 | 58.47% |
| Mar 31, 2025 | 39.53% |
| Dec 31, 2024 | 55.80% |
| Sep 30, 2024 | 71.54% |
| Jun 30, 2024 | -22.58% |
| Mar 31, 2024 | 43.45% |
| Dec 31, 2023 | -36.68% |
| Sep 30, 2023 | -36.43% |
| Jun 30, 2023 | -79.91% |
| Mar 31, 2023 | -74.22% |
| Dec 31, 2022 | -74.72% |
| Sep 30, 2022 | 33.66% |
| Jun 30, 2022 | -171.83% |
| Mar 31, 2022 | -125.76% |
| Dec 31, 2021 | 36.47% |